JP2024149655A5 - - Google Patents

Download PDF

Info

Publication number
JP2024149655A5
JP2024149655A5 JP2024127925A JP2024127925A JP2024149655A5 JP 2024149655 A5 JP2024149655 A5 JP 2024149655A5 JP 2024127925 A JP2024127925 A JP 2024127925A JP 2024127925 A JP2024127925 A JP 2024127925A JP 2024149655 A5 JP2024149655 A5 JP 2024149655A5
Authority
JP
Japan
Prior art keywords
protein
compound
kras
presenter
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024127925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024149655A (ja
Filing date
Publication date
Priority claimed from JP2019211918A external-priority patent/JP2020063256A/ja
Application filed filed Critical
Publication of JP2024149655A publication Critical patent/JP2024149655A/ja
Publication of JP2024149655A5 publication Critical patent/JP2024149655A5/ja
Priority to JP2025188241A priority Critical patent/JP2026015411A/ja
Pending legal-status Critical Current

Links

JP2024127925A 2015-01-09 2024-08-02 協同的結合に関与する化合物及びその使用方法 Pending JP2024149655A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025188241A JP2026015411A (ja) 2015-01-09 2025-11-07 協同的結合に関与する化合物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562101925P 2015-01-09 2015-01-09
US62/101,925 2015-01-09
JP2019211918A JP2020063256A (ja) 2015-01-09 2019-11-25 協同的結合に関与する化合物及びその使用方法
JP2022076767A JP2022093718A (ja) 2015-01-09 2022-05-06 協同的結合に関与する化合物及びその使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022076767A Division JP2022093718A (ja) 2015-01-09 2022-05-06 協同的結合に関与する化合物及びその使用方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025188241A Division JP2026015411A (ja) 2015-01-09 2025-11-07 協同的結合に関与する化合物及びその使用方法

Publications (2)

Publication Number Publication Date
JP2024149655A JP2024149655A (ja) 2024-10-18
JP2024149655A5 true JP2024149655A5 (https=) 2024-10-25

Family

ID=56356469

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2017555427A Pending JP2018507251A (ja) 2015-01-09 2016-01-08 協同的結合に関与する化合物及びその使用方法
JP2019211918A Pending JP2020063256A (ja) 2015-01-09 2019-11-25 協同的結合に関与する化合物及びその使用方法
JP2022076767A Pending JP2022093718A (ja) 2015-01-09 2022-05-06 協同的結合に関与する化合物及びその使用方法
JP2024127925A Pending JP2024149655A (ja) 2015-01-09 2024-08-02 協同的結合に関与する化合物及びその使用方法
JP2025188241A Pending JP2026015411A (ja) 2015-01-09 2025-11-07 協同的結合に関与する化合物及びその使用方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2017555427A Pending JP2018507251A (ja) 2015-01-09 2016-01-08 協同的結合に関与する化合物及びその使用方法
JP2019211918A Pending JP2020063256A (ja) 2015-01-09 2019-11-25 協同的結合に関与する化合物及びその使用方法
JP2022076767A Pending JP2022093718A (ja) 2015-01-09 2022-05-06 協同的結合に関与する化合物及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025188241A Pending JP2026015411A (ja) 2015-01-09 2025-11-07 協同的結合に関与する化合物及びその使用方法

Country Status (7)

Country Link
US (4) US10039839B2 (https=)
EP (3) EP4545521A3 (https=)
JP (5) JP2018507251A (https=)
AR (1) AR105755A1 (https=)
MA (1) MA41381A (https=)
TW (1) TW201629069A (https=)
WO (1) WO2016112279A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
EP3247378B8 (en) 2015-01-09 2023-08-23 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
TW201629069A (zh) * 2015-01-09 2016-08-16 霍普驅動生物科技股份有限公司 參與協同結合之化合物及其用途
EP4242304A3 (en) 2015-10-01 2024-02-07 Revolution Medicines, Inc. Methods and reagents for analyzing protein-protein interfaces
CN109641062A (zh) 2016-04-12 2019-04-16 华普卓威生物公司 用于产生化合物的组合物和方法
CA3058953A1 (en) * 2017-04-05 2018-10-11 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
IL269779B2 (en) * 2017-04-05 2026-04-01 Revolution Medicines Inc Methods and reagents for the analysis of protein-protein interfaces
WO2018195134A1 (en) * 2017-04-18 2018-10-25 X-Chem, Inc. Methods for identifying compounds
TW202132316A (zh) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras抑制劑
IL322454A (en) 2019-11-04 2025-09-01 Revolution Medicines Inc ras inhibitors
AU2020377925A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
CA3194067A1 (en) 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors
KR20240017811A (ko) 2021-05-05 2024-02-08 레볼루션 메디슨즈, 인크. 암의 치료를 위한 ras 억제제
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
CN116083290B (zh) * 2022-11-21 2024-06-14 陕西省微生物研究所 一种铅锌和/或抗生素和/或抗性基因污染土壤修复的复合微生物菌剂及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138807T1 (de) 1992-03-27 1996-06-15 American Home Prod 29-demethoxyrapamycin zur induktion der immunosuppression
CA2171629A1 (en) 1993-09-20 1995-03-30 Chaitan Khosla Recombinant production of novel polyketides
IL112873A (en) 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use
GB9410142D0 (en) 1994-05-20 1994-07-06 Univ Warwick Carbapenems
GB9524630D0 (en) * 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US5624677A (en) 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US6902913B2 (en) 1997-04-30 2005-06-07 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6153383A (en) 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
AU4093799A (en) * 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB9927191D0 (en) 1999-11-17 2000-01-12 Angeletti P Ist Richerche Bio Methods and means for regulation of gene expression
US20070203168A1 (en) * 2006-02-28 2007-08-30 Zhao Jonathon Z Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
WO2010031185A1 (en) 2008-09-19 2010-03-25 Protox Therapeutics Inc. Treating cancer stem cells using targeted cargo proteins
CN102224242B (zh) 2008-09-24 2014-09-24 中国科学院上海有机化学研究所 新基因簇
KR20110111321A (ko) 2009-01-30 2011-10-10 이난타 파마슈티칼스, 인코포레이티드 C형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
AU2010273220B2 (en) 2009-07-13 2015-10-15 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
US8664186B2 (en) 2009-07-24 2014-03-04 Universite De Lorraine Stambomycin and derivatives, their production and their uses as drugs
CN102712675A (zh) 2009-09-22 2012-10-03 爱勒让治疗公司 拟肽大环化合物
WO2011049157A1 (ja) 2009-10-22 2011-04-28 ペプチドリーム株式会社 ペプチド翻訳合成におけるrapidディスプレイ法
US9250237B2 (en) 2010-11-30 2016-02-02 The Johns Hopkins University Hybrid cyclic libraries and screens thereof
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012174489A2 (en) * 2011-06-15 2012-12-20 The Ohio State University Small molecule composite surfaces as inhibitors of protein-protein interactions
EP2806274A1 (en) 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
WO2015132784A1 (en) 2014-03-03 2015-09-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method and device for detection of pseudomonas aeruginosa
TW201629069A (zh) * 2015-01-09 2016-08-16 霍普驅動生物科技股份有限公司 參與協同結合之化合物及其用途
BR112021012057A2 (pt) * 2018-12-21 2021-10-19 Revolution Medicines, Inc. Compostos que participam de ligação cooperativa e usos dos mesmos

Similar Documents

Publication Publication Date Title
JP2024149655A5 (https=)
JP2023078174A5 (https=)
JP2020114828A5 (https=)
KR100254759B1 (ko) 단량체 및 이량체 항체-단편 융합 단백질
JP2009509535A5 (https=)
JP2022542431A5 (https=)
JP2024167313A5 (https=)
JP2021502810A5 (https=)
JP2021524270A5 (https=)
JP2020519643A5 (https=)
JP2022537931A5 (https=)
Tomlinson et al. [28] Methods for generating multivalent and bispecific antibody fragments
JP2021167329A5 (https=)
JP2010511388A5 (https=)
JPH08505623A (ja) 標的細胞への作用物質の輸送法
JPH03501440A (ja) 免疫反応性ヘテロ鎖抗体
JP2020524675A5 (https=)
Albrecht et al. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility
EP0637334B1 (fr) Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation
JP2021517471A5 (https=)
JP2024508709A5 (https=)
JP2023171909A5 (https=)
JP2020526497A5 (https=)
Hornig et al. Production of bispecific antibodies: diabodies and tandem scFv
JP2002529054A5 (https=)